Affluent Medical [AFME] vs Implanet S.A [ALIMP] Detailed Stock Comparison
Affluent Medical
Euronext
Loading...
Implanet S.A
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 16 vital metrics comparison: Affluent Medical wins in 5 metrics, Implanet S.A wins in 10 metrics, with 0 ties. Implanet S.A appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Affluent Medical | Implanet S.A | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -3.93 | -10.92 | Implanet S.A |
| Price-to-Book Ratio | 1.92 | N/A | N/A |
| Debt-to-Equity Ratio | 53.94 | -4.49 | Implanet S.A |
| EV/EBITDA | -5.40 | -12.96 | Implanet S.A |
| Profit Margin (TTM) | -275.50% | -43.35% | Implanet S.A |
| Operating Margin (TTM) | -124.38% | -36.86% | Implanet S.A |
| Return on Equity | -47.70% | -450.05% | Affluent Medical |
| Return on Assets (TTM) | -15.58% | -19.48% | Affluent Medical |
| Free Cash Flow (TTM) | $-11.47M | $-3.04M | Implanet S.A |
| 1-Year Return | -14.12% | 241.67% | Implanet S.A |
| Price-to-Sales Ratio (TTM) | 10.89 | 4.95 | Implanet S.A |
| Enterprise Value | $68.14M | $60.23M | Affluent Medical |
| EV/Revenue Ratio | 12.74 | 5.43 | Implanet S.A |
| Revenue per Share (TTM) | $0 | $0 | Affluent Medical |
| Earnings per Share (Diluted) | $-0.36 | $-0.04 | Implanet S.A |
| Beta (Stock Volatility) | 0.71 | 0.97 | Affluent Medical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Affluent Medical vs Implanet S.A Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Affluent Medical | -1.69% | -0.68% | -2.01% | 7.35% | 11.45% | 5.04% |
| Implanet S.A | -6.18% | -2.38% | 41.38% | 310.00% | 310.00% | 241.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Affluent Medical | -14.12% | -16.57% | -81.64% | -81.64% | -81.64% | -81.64% |
| Implanet S.A | 241.67% | 115.79% | -50.00% | -99.57% | -99.86% | -99.86% |
Performance & Financial Health Analysis: Affluent Medical vs Implanet S.A
| Metric | AFME | ALIMP |
|---|---|---|
| Market Information | ||
| Market Cap | €59.04M | €55.44M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 12,306 | 624,730 |
| 90 Day Avg. Volume | 8,974 | 904,078 |
| Last Close | €1.46 | €0.41 |
| 52 Week Range | €1.16 - €1.97 | €0.08 - €0.45 |
| % from 52W High | -25.95% | -8.89% |
| All-Time High | €8.60 (Jun 14, 2021) | €336.80 (Feb 17, 2014) |
| % from All-Time High | -83.02% | -99.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 6.40% | 0.41% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -2.76% | -0.43% |
| Operating Margin (TTM) | -1.24% | -0.37% |
| Return on Equity (TTM) | -0.48% | -4.50% |
| Debt to Equity (MRQ) | 53.94 | -4.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €0.77 | €-0.01 |
| Cash per Share (MRQ) | €0.17 | €0.00 |
| Operating Cash Flow (TTM) | €-11,324,000 | €-185,000 |
| Levered Free Cash Flow (TTM) | €-6,390,000 | €537,125 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Affluent Medical vs Implanet S.A
| Metric | AFME | ALIMP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -3.93 | -10.92 |
| Forward P/E | -2.02 | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 10.89 | 4.95 |
| Price to Book (MRQ) | 1.92 | N/A |
| Market Capitalization | ||
| Market Capitalization | €59.04M | €55.44M |
| Enterprise Value | €68.14M | €60.23M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 12.74 | 5.43 |
| Enterprise to EBITDA | -5.40 | -12.96 |
| Risk & Other Metrics | ||
| Beta | 0.71 | 0.97 |
| Book Value per Share (MRQ) | €0.77 | €-0.01 |
Financial Statements Comparison: Affluent Medical vs Implanet S.A
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AFME | ALIMP |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AFME | ALIMP |
|---|---|---|
| Cash & Equivalents | €1.23M | €1.60M |
| Total Current Assets | €12.16M | €10.32M |
| Total Current Liabilities | €9.53M | €12.21M |
| Long-Term Debt | €14.59M | €1.74M |
| Total Shareholders Equity | €30.27M | €727,000 |
| Retained Earnings | €-70.85M | €-4.37M |
| Property, Plant & Equipment | €235,000 | €4.25M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AFME | ALIMP |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AFME | ALIMP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 12,306 | 624,730 |
| Average Daily Volume (90 Day) | 8,974 | 904,078 |
| Shares Outstanding | 39.17M | 124.97M |
| Float Shares | 10.97M | 32.26M |
| % Held by Insiders | 0.22% | 0.75% |
| % Held by Institutions | 0.60% | 0.00% |
Dividend Analysis & Yield Comparison: Affluent Medical vs Implanet S.A
| Metric | AFME | ALIMP |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |